Pharmacy and Poisons Board recalls cancer drug over safety
Health & Science
By
Stephanie Wangari
| Dec 06, 2024
The Pharmacy and Poisons Board has warned against using the cancer drug Flurasted 500 from Batch Number HHP24017, citing safety concerns.
In a statement posted on X on Thursday, the Board urged the public to cease using the drug immediately and to report any related issues.
“All pharmaceutical outlets, healthcare facilities, healthcare professionals, and members of the public are directed to quarantine the affected batch immediately and halt its distribution, sale, issuance, or use,” the statement read.
The Board’s CEO, Fred Siyoi, explained that a market complaint regarding the appearance of the drug prompted the action.
READ MORE
Directline insurance moves to repair image amid shareholder wrangles
New KRA boss Muriithi wants outdated annual Finance Bill scrapped
Kenya-UAE deal could be a catalyst for job creation and an economic booster
Survey reveals housing project has missed the mark, is doomed to fail
TikTok's US future in limbo after Supreme Court ruling
End of the road for CMC Motors as auto dealer to close shop
Prateek Suri: How the richest Indian billionaire in Africa is increasing ties through innovation
Kenya to host top African logistics event
The public is encouraged to report suspected cases of substandard medicines or adverse drug reactions to the nearest healthcare facility or directly to the Pharmacy and Poisons Board.